| Term 
 | Definition 
 
        | - Sulfonylurea antidiabetic agent that increases insulin secretion from the pancreas - DM Type II
 |  | 
        |  | 
        
        | Term 
 
        | Insulin rapid/short acting Lispro Glulisine Regular |  | Definition 
 
        | - Binds to endogenous insulin receptor - DM type I or II
 |  | 
        |  | 
        
        | Term 
 
        | Insulin intermediate/long acting NPH glargine detemir |  | Definition 
 
        | - Binds to endogenous insulin receptor - DM Type I or II
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - Biguanidine antidiabetic; decreases hepatic glucose production and increases insulin sensitivity - DM Type II
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - Insulin sensitizer, improves insulin action in the presence of insulin - DM Type II
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - DPP-4 inhibitor - DM Type II
 |  | 
        |  |